Showing results (171-180 of 771) with videos related to
Sort By:
Pageof 78
Advanced Materials (Deerfield Beach, Fla.)|April 24, 2024
AMPLON: Amplifying DNA with Multiarm Priming and Looping Optimization of Nucleic AcidMert Tunca Doganay, Ethan Roman, Andrea M Hujer, et al.The Lancet. HIV|January 6, 2025
Target product profile for cell-based and gene-based therapies to achieve a cure for HIVSharon R Lewin, Cathy Bansbach, Dominic Kemps, et al.Current HIV Research|June 28, 2021
Accumulation of HIV-1 Drug Resistance Mutations and Methamphetamine UseHong-Ha M Truong, Robin Fatch, Steven G Deeks, et al.The Journal of Clinical Investigation|June 24, 2020
Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activationYang-Hui Jimmy Yeh, Katharine M Jenike, Rachela M Calvi, et al.Circulation|March 17, 2004
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infectionPriscilla Y Hsue, Joan C Lo, Arlana Franklin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2005
High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infectionPeter V Chin-Hong, Steven G Deeks, Teri Liegler, et al.The Journal of Infectious Diseases|June 15, 2004
Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimatesDavid R Bangsberg, Travis C Porco, C Kagay, et al.Journal of Virology|October 9, 2002
Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adultsJason D Barbour, Terri Wrin, Robert M Grant, et al.AIDS Research and Therapy|October 19, 2021
Considerations for designing and implementing combination HIV cure trials: findings from a qualitative in-depth interview study in the United StatesKarine Dubé, John Kanazawa, Lynda Dee, et al.The Journal of Infectious Diseases|March 27, 2012
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studiesKatherine Tassiopoulos, Alan Landay, Ann C Collier, et al.Pageof 78